共 50 条
Clinical manifestations of COVID-19: An overview of 102 systematic reviews with evidence mapping
被引:20
|作者:
Luo, Xufei
[1
]
Lv, Meng
[2
,3
,4
]
Zhang, Xianzhuo
[5
]
Estill, Janne
[6
,7
]
Yang, Bo
[8
]
Lei, Ruobing
[2
,3
,4
]
Ren, Mengjuan
[1
]
Liu, Yunlan
[1
]
Wang, Ling
[1
]
Liu, Xiao
[1
]
Wang, Qi
[9
,10
]
Meng, Min
[2
,3
,4
,11
]
Chen, Yaolong
[1
,2
,12
,13
,14
,15
,16
,17
,18
,19
]
机构:
[1] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China
[2] Chongqing Med Univ, Dept Pediat, Chevidence Lab Child & Adolescent Hlth, Childrens Hosp,Res Inst, Chongqing, Peoples R China
[3] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Minist Educ,Childrens Hosp, Key Lab Child Dev & Disorders,China Int Sci & Tec, Chongqing, Peoples R China
[4] Chongqing Key Lab Pediat, Chongqing, Peoples R China
[5] Lanzhou Univ, Sch Clin Med 1, Lanzhou, Peoples R China
[6] Univ Geneva, Inst Global Hlth, Geneva, Switzerland
[7] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland
[8] Shapingba Dist Ctr Dis Control & Prevent Chongqin, Dept Immune Programming & Management, Chongqing, Peoples R China
[9] McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[10] McMaster Univ, McMaster Hlth Forum, Hamilton, ON, Canada
[11] Gansu Prov Hosp, Dept Pharm, Lanzhou, Peoples R China
[12] Lanzhou Univ, Res Unit Evidence Based Evaluat & Guidelines, Chinese Acad Med Sci 2021RU017, Sch Basic Med Sci, Lanzhou, Peoples R China
[13] Lanzhou Univ, Inst Hlth Data Sci, Lanzhou 730000, Peoples R China
[14] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Peoples R China
[15] Lanzhou Univ, WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Peoples R China
[16] Guideline Int Network Asia, Lanzhou, Peoples R China
[17] Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China
[18] Lanzhou Univ, Grade Ctr, Lanzhou, Peoples R China
[19] Lanzhou Univ, Affiliate Cochrane China Network, Lanzhou, Peoples R China
关键词:
clinical manifestations;
COVID-19;
evidence map;
SARS-CoV-2;
systematic review;
SYMPTOMS;
D O I:
10.1111/jebm.12483
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objective Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, but there is so far no comprehensive analysis of all known symptoms of the disease. Our study aimed to present a comprehensive picture of the clinical symptoms of COVID-19 using an evidence map. Methods We systematically searched MEDLINE via PubMed, Web of Science, Embase, and Cochrane library from their inception to March 16, 2021. We included systematic reviews reporting the clinical manifestations of COVID-19 patients. We followed the PRISMA guidelines, and the study selection, data extraction, and quality assessment were done by two individuals independently. We assessed the methodological quality of the studies using AMSTAR. We visually presented the clinical symptoms of COVID-19 and their prevalence. Results A total of 102 systematic reviews were included, of which, 68 studies (66.7%) were of high quality, 19 studies (18.6%) of medium quality, and 15 studies (14.7%) of low quality. We identified a total of 74 symptoms including 17 symptoms of the respiratory system, 21 symptoms of the neurological system, 10 symptoms of the gastrointestinal system, 16 cutaneous symptoms, and 10 ocular symptoms. The most common symptoms were fever (67 studies, ranging 16.3%-91.0%, pooled prevalence: 64.6%, 95%CI, 61.3%-67.9%), cough (68 studies, ranging 30.0%-72.2%, pooled prevalence: 53.6%, 95%CI, 52.1%-55.1%), muscle soreness (56 studies, ranging 3.0%-44.0%, pooled prevalence: 18.7%, 95%CI, 16.3%-21.3%), and fatigue (52 studies, ranging 3.3%-58.5%, pooled prevalence: 29.4%, 95%CI, 27.5%-31.3%). The prevalence estimates for COVID-19 symptoms were generally lower in neonates, children and adolescents, and pregnant women than in the general populations. Conclusion At least 74 different clinical manifestations are associated with COVID-19. Fever, cough, muscle soreness, and fatigue are the most common, but attention should also be paid to the rare symptoms that can help in the early diagnosis of the disease.
引用
收藏
页码:201 / 215
页数:15
相关论文